Imaging Shows Brain Connection Breakdown In Early Alzheimer's Disease

Imaging Shows Brain Connection Breakdown In Early Alzheimer's Disease
Structural connectomes (top two rows) and
corresponding florbetapir PET images (bottom two
 rows) in four patients with normal cognition (NC)
 with the lowest whole cortex amyloid burden (left)
 and the four patients with AD with the highest whole
 cortex amyloid burden (right) focused on the
composite regions used in connectome versus amyloid
analysis. Nodes represent the centroids of the FreeSurfer
 parcellations in the frontal (red), cingulate (green),
temporal (light blue), and parietal (dark blue) regions.
This is merely a schematic intended to show the
concepts and is not intended to show any visually
discernible generalizable difference between the
patients with NC and those with AD. Structural
network metrics provide more sensitive information
about the connectome than are apparent through
visualization alone. (Credit: RSNA)
Changes in brain connections visible on MRI could represent an imaging biomarker of Alzheimer's disease, according to a new study presented today at the annual meeting of the Radiological Society of North America (RSNA).

Alzheimer's disease is the most common form of dementia. As many as 5 million Americans are affected, a number expected to grow to 14 million by 2050, according to the Centers for Disease Control and Prevention. Preventive treatments may be most effective before Alzheimer's disease is diagnosed, such as when a person is suffering from mild cognitive impairment (MCI), a decline in cognitive skills that is noticeable but not severe enough to affect independent function. Previous efforts at early detection have focused on beta amyloid, a protein found in abnormally high amounts in the brains of people with Alzheimer's disease.

For the new study, researchers looked at the brain's structural connectome, a map of white matter tracts that carry signals between different areas of the brain. They analyzed the results from 102 patients enrolled in a national study called the Alzheimer's Disease Neuroimaging Initiative (ADNI) 2. The patients had undergone diffusion tensor imaging (DTI), an MRI method that assesses the integrity of white matter tracts in the brain by measuring how easy it is for water to move along them.
The researchers correlated changes in the structural connectome with results from florbetapir positron emission tomography (PET) imaging, a technique that measures the amount of beta amyloid plaque in the brain. Increased florbetapir uptake corresponds with greater amounts of the protein. The results showed a strong association between florbetapir uptake and decreases in strength of the structural connectome in each of the five areas of the brain studied.
Based on these findings, DTI may offer a role in assessing brain damage in early Alzheimer's disease and monitoring the effect of new therapies. Traditionally, Alzheimer's disease is believed to exert its effects on thinking via damage to the brain's gray matter, where most of the nerve cells are concentrated. This study suggests that amyloid deposition in the gray matter affects the associated white matter connections, which are essential for conducting messages across the billions of nerve cells in the brain, allowing for all aspects of mental function. The researchers suspect that as amyloid plaque load in the gray matter increases, the brain's white matter starts to break down or malfunction and lose its ability to move water and neurochemicals efficiently.
The researchers plan to continue studying this cohort of patients over time to gain a better understanding of how the disease evolves in individual patients. They also intend to incorporate functional imaging into their research to learn about how the relationship between function and structure is affected with increasing amyloid burden.